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Objectives This study sought to determine the efficacy of dietary sodium restriction (DSR) for improving vascular endothe-
lial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure (SBP) (130–159
mm Hg) and the associated physiological mechanisms.
Background Vascular endothelial dysfunction develops with advancing age and elevated SBP, contributing to increased car-
diovascular risk. DSR lowers BP, but its effect on vascular endothelial function and mechanisms involved are
unknown.
Methods Seventeen subjects (11 men and 6 women; mean age, 62  7 years) completed a, randomized crossover study
of 4 weeks of both low (DSR) and normal sodium intake. Vascular endothelial function (endothelium-dependent
dilation; EDD), nitric oxide (NO)/tetrahydrobiopterin (BH4) bioavailability, and oxidative stress-associated mecha-
nisms were assessed following each condition.
Results Urinary sodium excretion was reduced by 50% (to 70  30 mmol/day), and conduit (brachial artery flow-
mediated dilation [FMDBA]) and resistance (forearm blood flow responses to acetylcholine [FBFACh]) artery EDD
were 68% and 42% (peak FBFACh) higher following DSR (p  0.005). Low sodium markedly enhanced NO-
mediated EDD (greater FBFACh with endothelial NO synthase inhibition) without changing endothelial NO syn-
thase expression/activation (Ser 1177 phosphorylation), restored BH4 bioactivity (less FMDBA with acute BH4),
abolished tonic superoxide suppression of EDD (less FMDBA and FBFACh with ascorbic acid infusion), and in-
creased circulating superoxide dismutase activity (all p  0.05). These effects were independent of SBP. Other
subject characteristics/dietary factors and endothelium-independent dilation were unchanged.
Conclusions DSR largely reversed both macro- and microvascular endothelial dysfunction by enhancing NO and BH4 bioavail-
ability and reducing oxidative stress. Our findings support the emerging concept that DSR induces “vascular pro-
tection” beyond that attributable to its BP-lowering effects. (J Am Coll Cardiol 2013;61:335–43) © 2013 by
the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.010Cardiovascular disease (CVD) remains the leading cause of
death in the United States, and the risk for CVD increases
progressively with age (1). Vascular endothelial dysfunction,
as reflected by impaired endothelium-dependent dilation
(EDD) of conduit arteries and/or resistance vessels (2), is a
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accepted September 11, 2012.predictor of CVD and CV events (3,4). EDD is reduced in
middle-aged and older adults in the absence of major risk
factors or clinical CVD (5). Systolic blood pressure (SBP)
also increases with advancing age (6), resulting in 65% of
adults 50 years of age and older with SBP130 mm Hg (7).
Importantly, the age-associated impairment of EDD is even
greater in middle-aged and older adults with elevated
compared with normal SBP (2,8).
See page 344
Dietary sodium restriction is a commonly recom-
mended lifestyle modification for reducing the risk for
CVD (9). Based on recent analyses, the projected health
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DSR and Vascular Function January 22, 2013:335–43and societal benefits resulting
from population-wide dietary
sodium restriction (DSR) would
be substantial (10). To date, such
projections have focused on the
effects of DSR on BP. However,
high dietary sodium intake has
adverse cardiovascular effects in-
dependent of BP (11,12). Evi-
dence from animal models and
acute salt loading or cross-
sectional observations in humans
suggests a negative association
between sodium intake and
vascular endothelial function
(11,13–16). However, presently
it is unknown whether DSR can
reverse endothelial dysfunction
in the common clinical setting of
aging and elevated SBP.
The physiological mechanisms
by which DSR may improve vas-
cular endothelial function in hu-
mans are also unknown. Avail-
able data from rodent models suggest that high-sodium
diets may impair EDD by reducing nitric oxide (NO)
bioavailability as a result of oxidative stress (14,17). This
may be mediated via oxidation and reduced bioavailability of
tetrahydrobiopterin (BH4) (18), an essential cofactor for
ndothelial nitric oxide synthase [eNOS]-mediated NO
roduction, which causes uncoupling of the enzyme (14,18).
imited data in rodents suggest that high sodium also may
educe the expression of eNOS (19) and suppress the
ctivity of superoxide dismutase (SOD), an important an-
ioxidant enzyme (20).
The aim of this study was to determine whether DSR
mproves vascular endothelial dysfunction in middle-aged/
lder adults with moderately elevated SBP by increasing
O and BH4 bioavailability and reducing oxidative stress.
Methods
Using a double-blind, placebo-controlled, randomized cross-
over design, both conduit artery (macrocirculatory) and
resistance vessel (microcirculatory) EDD, as were the puta-
tive physiological mechanisms involved, were determined
under well-controlled conditions of low (DSR) and normal
dietary sodium intake. Vascular NO and BH4 bioavailability
and oxidative stress were assessed by “pharmaco-dissection”
using agents that either inhibited or enhanced these pro-
cesses, whereas eNOS protein expression and activation
(phosphorylation at Ser 1177) were measured in endothelial
cells obtained from arterial sampling.
The study was conducted in the University of Colorado-
Boulder Clinical and Translational Research Center
Abbreviations
and Acronyms
BH4  tetrahydrobiopterin
CTRC  Clinical and
Translational Research
Center
CVD  cardiovascular
disease
DSR  dietary sodium
restriction
EDD  endothelium-
dependent dilation
eNOS  endothelial nitric
oxide synthase
FBFACh  forearm blood
flow to acetylcholine
FMDBA  brachial artery
flow-mediated dilation
NO  nitric oxide
SBP  systolic blood
pressure
SOD  superoxide
dismutase(CTRC), and blood and urine assays were performed at theColorado Clinical Translational Sciences Institute CTRC
Core Lab, University of Colorado–Denver Anschutz Med-
ical Campus.
Subjects. Enrolled subjects were 50 to 79 years of age and
had a SBP of 130 to 159 mm Hg (i.e., high-normal or stage I
systolic hypertension), with diastolic BP 99 mm Hg,
verified on a minimum of 2 occasions, as described previ-
ously (21,22). These criteria were chosen to encompass the
resting BP values of the majority of middle-aged and older
adults at higher BP-related risk for CVD (7,23). Enrolling
subjects with high-normal and stage I hypertension also
increased the likelihood of assessing adults who were more
salt-sensitive at baseline, as salt sensitivity increases with
increasing resting BP (24). All subjects were otherwise free
of CVD, diabetes, kidney disease, and other clinical disor-
ders. Details of inclusion and exclusion criteria can be found
in the Online Appendix.
Twenty middle-aged and older men and women were
enrolled in the study (see Online Figure for CONSORT
diagram). Three subjects withdrew after beginning DSR
(see subsequent discussion), but prior to completing the first
set of vascular measurements (1 was uncomfortable with
study procedures; 2 decided that they could not comply with
the diet). The remaining 17 subjects (ages 51 to 77 years; 11
men and 6 post-menopausal women) completed the entire
10-week protocol. All procedures were approved by the
institutional review board of the University of Colorado at
Boulder. The nature, benefits, and risks of the study were
explained to the volunteers and their written informed
consent was obtained prior to participation.
Experimental design and dietary sodium restriction. A
double-blind, placebo-controlled, randomized crossover de-
sign, originally described by Cappuccio et al. (25) and more
recently by our group (21), was used. A low sodium target of
50 mmol/day (1,200 mg/day) was set, with the anticipation
that actual mean intake would be 65 mmol/day (1,500
mg/day), consistent with the DASH (Dietary Approaches
to Stop Hypertension) diet (26). This was compared to the
mean (“normal”) U.S. sodium intake of 150 mmol/day
(3,600 mg/day) based on recent National Health and
Nutrition Examination Survey dietary intake data (27).
During the entire 10-week intervention period, subjects were
instructed to reduce their dietary sodium intake to a target
of 50 mmol/day and to take a total of 10 tablets through-
out the day, with meals. For 5 of the weeks, the tablets were
placebo pills, whereas for the other 5 weeks, the tablets were
slow-release sodium chloride tablets (10 mmol [0.23 g] per
tablet) (HK Pharma Ltd., Hitchin, United Kingdom). The
slow-release salt tablets aimed to return sodium intake to
the 150 mmol/day target.
Following screening, subjects were provided with com-
prehensive dietary education and counseling by CTRC
bionutritionists to reduce dietary sodium intake without
changing caloric intake, dietary composition, or potassium
intake. Vascular measurements were performed after 4
weeks (i.e., during the fifth week) of each condition. Details
t1
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Appendix.
Blood pressure, clinical characteristics, assays, and diet
analysis. Brachial artery BP was assessed under quiet rest-
ing conditions, with the subject in the supine position, using
a semiautomated device (Dynamap XL, Johnson & John-
son, Raritan, New Jersey) in accordance with the Joint
National Committee guidelines (28), as described previously
(21). SOD activity was measured in plasma samples (n 12
of 13) using a commercially available colorimetric kit (Cell
Technology, Inc., Mountain View, California) (29).
Twenty-four-hour urinary sodium and potassium excretion
values were measured weekly as a quantitative maker of
dietary intake (Fig. 1). CTRC bionutritionists analyzed a
3-day diet record logged by subjects at baseline and at the end
of each sodium condition, as described previously (21). For
details of these measurements, as well as assessments of other
subject characteristics, please see the Online Appendix.
Conduit artery endothelium-dependent and -independent
dilation. Brachial artery flow-mediated dilation (FMDBA),
estimated peak shear rate, and endothelium-independent
dilation (brachial artery dilation to 0.4 mg of sublingual
nitroglycerin) were determined using duplex ultrasonogra-
phy (Power Vision 6000, Toshiba Corp., Tokyo, Japan)
with a 7.5-MHz adjustable (6 to 11 MHz) linear array
transducer, as described previously (30,31). BH4 modula-
ion of EDD was determined by measuring FMDBA3 hrs
after oral administration of BH4 or placebo tablets (32) (n
4/15), and the influence of oxidative stress on FMDBA was
assessed by infusing a supraphysiological dose of ascorbic
acid or isovolumic saline during each of these visits (BH4
and placebo days), as described previously (31,33) (n  12
to 17). See the Online Appendix for details.
Resistance vessel endothelium-dependent and -independent
dilation. Forearm blood flow (FBF) was measured in the
experimental (catheterized) and the control forearm with
strain-gauge venous occlusion plethysmography (AI6 Arte-
rial Inflow System, D.E. Hokanson Inc., Bellevue, Wash-
ington), as previously described (n  12 of 13) (34). All
FBF values are presented as percentage increases in flow
Figure 1 Twenty-Four-Hour Urinary Sodium and Potassium Excr
The 24-h urinary excretion of sodium (left) and potassium (right) at baseline (B),
sodium condition (dietary sodium restriction [DSR]) (L1 to L5). Values are mean 
(repeated measures analysis of variance with post hoc Bonferonni corrected comp(ml/100 ml forearm tissue/min) in response to intrabrachial
artery drug infusion (acetylcholine [ACh], sodium nitro-
prusside, ACh  NG monomethyl-L-arginine or ACh 
ascorbic acid) compared with saline control. Forearm vas-
cular conductance (FVC) was calculated from intra-arterial
BP and FBF (FVC  FBF/mean arterial pressure) to
account for any differences in arterial BP between sodium
conditions. See the Online Appendix for details.
Endothelial cell protein assessments. The procedures for
collection and analysis of arterial endothelial have been
described in detail previously (30,31). Vascular endothelial
cells were obtained from the brachial artery and analyzed for
expression of total eNOS and eNOS phosphorylated at Ser
1177 using immunofluorescence imaging (n  12/13). For
details, please see the Online Appendix.
Statistics. Changes in EDD in response to dietary sodium
restriction (DSR vs. normal sodium condition) were ana-
lyzed using a series of linear mixed-effects models (Online
Table 1; see Online Appendix for details and power calcu-
lations). Differences in other variables were assessed using
paired t tests (between sodium conditions) or repeated
measures analysis of variance with post hoc Bonferonni
corrected comparisons (sodium conditions vs. baseline).
Bivariate relations were determined using the Pearson
correlation coefficient. All data are reported as mean  SD.
Results
Clinical characteristics and efficacy of DSR. Subjects
were non-Hispanic Caucasian (88%) or Asian (12%) with a
mean age of 62  7 years (Table 1). They successfully
reduced sodium intake without altering potassium intake
based on both urinary excretion (sodium: 151  37 mmol/
day, baseline; 153  27 mmol/day, normal sodium condi-
tion; 70 30 mmol/day, DSR [week-5 values]) (Fig. 1) and
dietary analysis (Table 2). Other than sodium intake, diet
composition was unchanged (Table 2). As anticipated, SBP
was reduced during DSR, but other clinical characteristics,
including diastolic BP, were unaffected (Table 1). Circulat-
ing humoral factors also were unchanged (Table 3).
1-5 of the normal sodium condition (N1 to N5) and weeks 1 to 5 of the low
p  0.001; †p  0.005 versus baseline or normal sodium of same week
s; n  17).etion
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DSR and Vascular Function January 22, 2013:335–43Effects of DSR on conduit artery (macrocirculatory)
endothelial function. FMDBA was 68% greater during
SR versus normal sodium condition (%: 6.01  2.31 vs.
.57  1.69; p  0.001) (Fig. 2A). The response was
onsistent with all but 2 subjects demonstrating higher
MDBA with DSR versus the normal sodium state (Fig. 2B).
When the 2 sodium conditions were pooled, there was a
significant inverse correlation between sodium excretion and
FMDBA (r  –0.48; p  0.01). The difference in FMDBA
between sodium conditions remained significant (p 
.001) after corrections for SBP and medication use, and
SBP with DSR did not correlate with FMDBA (r 
0.05; p  0.85). No trends for sex differences were
bserved, although the study was not powered to detect
uch differences. Baseline brachial artery diameter and shear
ate did not differ across sodium conditions (Table 4) or
ith ascorbic acid with or without BH4 administration,
nd the difference in FMDBA between conditions re-
Clinical CharacteristicsTable 1 Clinical Characteristics
Characteristic Baseline Low Sodium Normal Sodium
Mass (kg) 80.5 17.5 79.3 17.1 79.8 17.4
Body mass index (kg/m2) 27.1 4.1 26.4 4.2 26.6 4.3
Systolic blood pressure (mm
Hg)
138 7 128 10* 140 15
Diastolic blood pressure (mm
Hg)
83 7 79 6 82 6
Total cholesterol (mg/dl) 196 27 187 27 194 22
LDL cholesterol (mg/dl) 123 23 118 21 127 23
HDL cholesterol (mg/dl) 52 16 49 16 50 15
Triglycerides (mg/dl) 104 61 98 39 88 42
Fasting glucose (mg/dl) 80 16 81 15 78 15
Plasma sodium (mmol) 139.4 2.7 138.1 2.8 139.0 1.8
Creatinine clearance
(ml/min/1.73 m2)
96 16 92 26 99 29
MDRD eGFR (ml/min/1.73 m2) 81 13 82 15 86 19
PA (ActiGraph) (kcal/week) N/A 3242 1285 3016 1320
PA (questionnaire)
(MET h/week)
N/A 27 29 28 28
Values are mean  SD. ActiGraph (accelerometer) data are on a subsample of 10 subjects. *p 
.01 versus baseline or normal sodium.
eGFR  estimated glomerular filtration rate (Modification of Diet in Renal Disease Study
quation); HDL  high-density lipoprotein; LDL  low-density lipoprotein; MET  metabolic
quivalent; N/A  not applicable; PA  physical activity.
Diet CompositionTable 2 Diet Composition
Component Baseline Low Sodium Normal Sodium
Total intake (kcal/day) 2191 562 2045 509 2019 466
Carbohydrates (% of total kcal) 47 8 52 9 47 12
Protein (% of total kcal) 16 3 15 3 17 3
Fat (% of total kcal) 34 6 33 9 33 9
Calcium (mmol/day) 23 8 19 6 19 5
Magnesium (mmol/day) 11 5 12 5 11 3
Potassium (mmol/day) 63 18 64 17 64 18
Sodium (mmol/day)† 136 48 56 15* 57 12*
Fruits and vegetables (cups/day) 3.7 1.9 3.6 1.6 3.7 1.8Values are mean  SD. *p  0.01 versus baseline. †Sodium intake was based on 3-day diet
records and excludes sodium added back in pill form.ained significant (p  0.001) when covarying for these
actors. Endothelium-independent dilation to sublingual
itroglycerin was unaffected by DSR (Table 4). The
ssociated mixed-effects regression models are shown in
nline Table.
ffects of DSR on resistance vessel (microcirculatory)
ndothelial function. DSR improved EDD to ACh,
hether expressed as FBF (42% at peak dose) or as
P-corrected forearm vascular conductance (52% at peak
Figure 2 Brachial Artery Flow-Mediated Dilation
Mean percentage changes in group (A) and individual subject (B) brachial
artery flow-mediated dilation (FMD) during normal-sodium (NS) conditions ver-
sus low-sodium (LS) conditions (DSR). Values are mean  SE. *p  0.001
versus normal-sodium condition (linear mixed-effects models [see Online
Appendix for details]); n  16/17). All 17 subjects are shown in B, but due to
similarities, some subjects’ data overlap and may not be individually
distinguishable.
Circulating Humoral FactorsTable 3 Circulating Humoral Factors
Factor Low Sodium Normal Sodium p Value
Log C-reactive protein (mg/l) 0.27 0.53 0.15 0.51 0.53
Log interleukin-6 (pg/ml) 0.13 0.25 0.08 0.32 0.59
Log tumor necrosis factor  (pg/ml) 0.05 0.10 0.03 0.17 0.66
Angiotensin II (pg/ml) 4.7 2.7 3.9 2.3 0.42
Plasma renin activity (ng/ml/h) 1.48 1.2 0.84 0.54 0.36
Aldosterone (ng/dl) 5.7 2.6 4.1 1.6 0.32
Endothelin-1 (pg/ml) 6.3 1.4 5.9 1.3 0.58
Norepinephrine (pg/ml) 400 170 392 140 0.88
Cystatin C (mg/l) 0.76 0.15 0.77 0.13 0.93
Insulin (U/ml) 11.4 4.7 9.3 3.9 0.19
Values are mean  SD.
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January 22, 2013:335–43 DSR and Vascular Functiondose) (both, p  0.05) (Figs. 3A and 3B). EDD also was
greater with DSR versus the normal sodium state when
expressed as area under the dose–response curve (Table 4).
Again, the effect of DSR was consistent among the subjects,
with all but 2 individuals demonstrating higher values for
area under the dose–response curve of FBFACh compared
ith the normal sodium state (Fig. 3C). The FBF and FVC
esponses to the endothelium-independent dilator sodium
itroprusside were unchanged across sodium conditions
Table 4). FBFACh in the control arm did not change with
sodium condition or drug infusions (not shown).
Effects of DSR on EDD: NO bioavailability. Coinfusion
of the eNOS inhibitor NG monomethyl-L-arginine mark-
edly reduced FBFACh and BP-corrected FVC with DSR
ut not during the normal sodium condition (Figs. 4A to 4D).
s a result, FBFACh no longer differed between DSR and
he normal sodium condition during eNOS inhibition,
ndicating increased NO bioavailability during DSR. In
ascular endothelial cells sampled from the brachial artery,
NOS protein expression and activation, the latter indicated
y phosphorylation at Ser 1177, did not differ between
odium conditions (Figs. 4E and 4F).
ffects of DSR on EDD: oxidative stress and BH4
bioavailability. Infusion of ascorbic acid increased FMDBA
during the normal sodium condition (37%; p  0.05), but
not during DSR (Fig. 5A), indicating reduced oxidative
stress–related suppression of EDD during DSR. Similarly,
oral BH4 administration improved FMDBA only in the
normal sodium state (65%; p  0.005) (Fig. 5A). No
further improvement in FMDBA was observed when ascor-
bic acid and BH4 were coadministered (Fig. 5A). FMDBA
no longer differed between DSR and the normal sodium
condition following the administration of ascorbic acid
and/or BH4. These responses were independent of the
odium condition–related influence on SBP. Endothelium-
ndependent dilation to nitroglycerin did not change with
scorbic acid  BH4 during either sodium condition (data
Hemodynamic FactorsTable 4 Hemodynamic Factors
Factor Low Sodium Normal Sodium p Value
Brachial artery FMD (mm ) 0.23 0.07 0.15 0.07 0.001
Baseline brachial artery
diameter (mm)
3.89 0.56 4.07 0.44 0.31
Peak shear rate (s1) 391 104 378 118 0.50
Brachial artery dilation to
NTG (% )
24.0 4.5 23.4 2.3 0.54
Brachial artery dilation to
NTG (mm )
0.91 0.14 0.91 0.15 0.82
AUC of % FBFACh vs. saline 1768 1002 1213 890 0.05
AUC of % FVCACh vs. saline 1811 1006 1220 873 0.05
AUC of % FBFSNP vs. saline 1035 377 995 635 0.93
AUC of % FVCSNP vs. saline 1040 465 1000 655 0.93
Values are mean  SD.
AUC  area under the curve; FBFACh  forearm blood flow to acetylcholine; FMD  flow-
mediated dilation; FVC  forearm vascular conductance; NTG  nitroglycerin; SNP  sodium
nitroprusside.not shown). Circulating SOD activity was modestly greater(p 0.05) during DSR versus the normal sodium condition
Fig. 5B).
Coinfusion of ascorbic acid also improved FBFACh (peak
dose: 57%) under the normal sodium condition compared
with DSR (Fig. 5C). FBFACh no longer differed between
DSR and the normal sodium condition during coinfusion of
ascorbic acid. Results were similar when EDD was ex-
pressed as forearm vascular conductance (Fig. 5D).
Figure 3 Forearm Blood Flow to Acetylcholine
Forearm blood flow (FBF) (A) and vascular conductance (VC) (B) responses to
acetylcholine (ACh) during NS conditions versus LS (DSR). Individual subject
FBFAch (area under the curve, AUC) (C). Values are mean  SE. *p  0.005;
†p  0.05 LS versus NS (linear mixed-effects model; n  12 of 13). Abbrevia-
tions as in Figure 2.
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The present findings show that restricting dietary sodium
intake to a level consistent with the DASH diet improves
both conduit artery (macrovascular) and resistance vessel
(microvascular) endothelial function in middle-aged/older
adults with moderately elevated SBP, a large clinical demo-
graphic with significant CVD risk burden. The results also
provide insight into humans regarding the physiological
mechanisms mediating improvements in vascular endothe-
lial function with DSR, which include increased NO and
BH4 bioavailability and reduced oxidative stress. None of
the vascular effects observed were related to changes in BP,
Figure 4 Contribution of eNOS to EDD
Dose-response for FBF (A) and forearm VC (B) to ACh with or without NG monome
thelial nitric oxide synthase (eNOS) protein (E) and eNOS phosphorylated at Ser 1
thelial cell (HUVEC) control; representative images shown below. Values are mean
effects model; n  12 of 13). Abbreviations as in Figures 2 and 3.other dietary factors, clinical characteristics, or humoral sinfluences. Overall, the findings support the emerging
concept that maintaining low dietary sodium intake exerts
“vasculoprotective” effects beyond those attributable to BP
lowering.
DSR and vascular endothelial function. The present
results demonstrate that DSR improves EDD as assessed by
both FMDBA, a measure of peripheral conduit artery
dilation to a mechanical (shear) stress, and FBFACh, an
ssessment of resistance vessel EDD in response to a
hemical stimulus. These findings are in agreement with
hose from previous reports of impaired EDD in animals
13,18) and younger humans (11,15) following a high
arginine (L-NMMA) during NS and LS (DSR); AUC values (C and D). Total endo-
eNOS) (F) in subjects’ endothelial cells relative to human umbilical vein endo-
. *p  0.001; †p  0.05 (drug  sodium condition interaction; linear mixed-thyl-L-
177 (P
 SEodium load, as well as improved FMDBA after short-term
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January 22, 2013:335–43 DSR and Vascular Functionsodium restriction in overweight/obese, normotensive adults
(35). The improvements in both micro- and macrocircula-
tory EDD with DSR in the present investigation were
observed in almost all subjects and did not differ between
the men and women studied. We also found that conduit
artery EDD (FMDBA) was inversely related to urinary
odium excretion, an objective measure of dietary sodium
ntake.
The reduction in SBP with low sodium (12 mm Hg) was
imilar to those from previous studies on dietary sodium
estriction (21,22) and was consistent with those from other
rossover studies employing well-controlled BP assessments
25,36). The present magnitude of reduction was observed
espite the inclusion of subjects on antihypertensive medi-
ations. Importantly, the improvements in EDD with DSR
emained significant after statistically correcting for SBP,
nd the changes in EDD were not related to the changes in
BP, whereas diastolic BP was unaffected. Thus, DSR
mproved vascular endothelial function beyond its influence
n BP alone.
hysiological mechanisms. High sodium intake in
ounger humans and rodents impairs EDD by reducing NO
ioavailability (13–15), and the chronic impairment in
DD in salt-sensitive compared with salt-resistant adults
Figure 5 Contributions of Oxidative Stress and BH4 Bioavailab
Brachial artery FMD during NS versus LS with or without coadministration of ascor
(SOD) activity (B). FBF (C) and forearm VC (D) responses to ACh  Vit C. Values
action or main effect of sodium condition; linear mixed-effects model; n  12 to 1ith hypertension is associated with reductions in bioavail-ble NO (37). Consistent with these observations, in the
resent study, lowering dietary sodium improved resistance
essel EDD by increasing NO bioavailability. The latter was
ot obviously associated with changes in eNOS or its
ctivation, as eNOS protein expression and phosphorylation
f eNOS at Ser 1177 did not differ between sodium
onditions in vascular endothelial cells obtained from bra-
hial artery sampling.
In rodents fed a high-salt diet, impairments in EDD are
inked to reduced bioavailability of BH4, an essential cofac-
tor for NO production by eNOS (18), as well as oxidative
stress (14,17), as indicated in part by improved EDD
following acute administration of an antioxidant (17). In the
present study, a single oral dose of BH4, previously shown to
mprove EDD in settings of endothelial dysfunction (32),
mproved EDD (FMDBA) during normal, but not low
sodium intake. Moreover, infusion of supraphysiological
doses of ascorbic acid (vitamin C), a well-established
method for acutely reducing oxidative stress-related sup-
pression of EDD (8,33), improved both conduit artery
(FMDBA) and resistance vessel (FBFACh) EDD during
ormal, but not lower, sodium intake. Indeed, the admin-
stration of BH4, ascorbic acid, or both abolished the
differences in EDD between the normal- and low-sodium
o EDD
id (Vit C) and/or tetrahydrobiopterin (BH4) (A). Circulating superoxide dismutase
an  SE. *p  0.001; †p  0.005; ‡p  0.05 (drug  sodium condition inter-
breviations as in Figures 2 and 3.ility t
bic ac
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7). Abconditions. A modest but significant increase in circulating
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DSR and Vascular Function January 22, 2013:335–43SOD activity was also found with DSR, in agreement with
the inhibitory effects of high-salt feeding on SOD reported
previously in rats (20).
BH4 bioavailability modulates NO-mediated EDD in
he absence of changes in eNOS protein expression or
ctivation (38). Without adequate BH4, eNOS is “uncou-
pled,” producing more superoxide anion and less NO (39).
It is possible that DSR “recoupled” eNOS, increasing NO
production without further activation of the enzyme. The
apparent increase in BH4 bioavailability with DSR most
ikely was mediated by reduced oxidative stress, as reactive
xygen species, particularly peroxynitrite formed by the
eaction of superoxide and NO, readily oxidize BH4 to its
nactive form, BH2 (39). Alternatively, DSR may have
ncreased NO bioavailability by inhibiting superoxide pro-
uction by oxidant enzymes such as NADPH oxidase or by
itochondria, resulting in less superoxide to react with/
educe the bioavailability of NO.
linical significance. The concept that high sodium in-
ake has adverse CV effects independent of BP has been
dvanced previously (9,12). High dietary sodium impairs
DD even in rodents that are salt-resistant and, thus, do
ot exhibit increases in BP in response to a high-salt diet
13,18,20). Acute impairment of EDD in normotensive
dults after sodium loading also is BP independent (11), and
dults with elevated SBP who report lower sodium intake
ave enhanced EDD independent of BP (16). The present
esults extend these findings to sodium restriction and lend
upport to the overall hypothesis that sodium intake not
nly elevates BP but also exerts other adverse influences
12). The effects of sodium restriction on endothelial func-
ion reported here also complement previous findings that
educing sodium intake can rapidly de-stiffen large elastic
rteries (21), another independent vascular risk factor for
VD (40). The improvements in these 2 common forms of
rterial dysfunction, both predictors of CV events (3,4,40),
uggest that DSR has strong potential for reducing CVD
isk via broad vasculoprotective effects.
trengths and limitations. Diet was well-controlled in the
resent study, with only sodium intake differing between the
conditions, as documented by “gold-standard” 24-hr urine
ollections combined with diet records. This feature, along
ith the placebo-controlled crossover design employed,
llowed for the isolation of dietary sodium as the modulat-
ng factor between conditions. Importantly, the results are
eneralizable to community settings in that sodium restric-
ion was achieved by subjects on their own, guided by
ietary counseling, rather than delivered as prepared meals
n a research setting. The assessments of macro- and
icrocirculatory endothelial function, both of which are
nvolved in age- and BP-related CV pathology, as well as
he unique insight into mechanisms of action acquired by
he use of novel translational research techniques, are
dditional strengths of the study.
Due to the complexity, burden, and, in some cases,
nvasiveness of the study design and procedures, only aimited number of subjects could be studied. However, as
ecently emphasized by Donald et al. (41), a much smaller
ample size is required when assessing EDD using a
rossover compared with a parallel-group design, as shown
n previous investigations (31,42). As such, the study was
ell powered to assess change in EDD (Online Appendix),
nd importantly, the approach allowed investigation of the
echanisms underlying the beneficial vascular effects of low
odium intake at a depth and level of detail that would not
e possible in large cohorts.
onclusions
he results of the present study support the hypothesis that
SR to a level consistent with the Dietary Approaches to
top Hypertension diet improves both conduit artery (ma-
rovascular) and resistance vessel (microvascular) endothe-
ial function in middle-aged/older men and women with
levated SBP by increasing NO and BH4 bioavailability and
educing oxidative stress. These findings provide further
upport for the idea that DSR has the potential to improve
V health and reduce the risk for CVD beyond its
P-lowering effects.
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APPENDIX
For a an expanded Methods section, and supplemental table and figure,
please see the online version of this article.
